The effects of dexamethasone (a synthetic glucocorticoid) and insulin on the secretion of very-low-density lipoprotein (VLDL) and high-density lipoprotein (HDL) were investigated. Rat hepatocytes in monolayer culture were preincubated for 15 h in the presence or absence of combinations of 100 nM-dexamethasone and 2 nM-, 10 nm-or 50 nM-insulin. Dexamethasone increased [3H]oleate incorporation into secreted triacylglycerol by 2.7-fold and the mass of triacylglycerol secreted by 1.5-fold. Insulin alone decreased these parameters and antagonized the effect of dexamethasone.
INTRODUCTION
The liver plays a central role in the metabolism of lipoproteins. It secretes VLDL and HDL components and removes from the circulation major proportions of chylomicron remnants, intermediate-density lipoproteins, LDL and HDL. The present work is concerned with the effects of insulin and glucocorticoids in regulating lipoprotein secretion by the liver.
Glucocorticoids stimulate the secretion of VLDL in vivo [1] [2] [3] , in perfused liver [4, 5] and in isolated hepatocytes [6] [7] [8] . By contrast, insulin on its own can inhibit the secretion of triacylglycerol, phospholipid, cholesterol ester, apo B and apo E in VLDL [6, 7, [9] [10] [11] [12] [13] [14] [15] . However, some investigators have observed no significant short-term effects of insulin on VLDL secretion [6, 16, 17] , whereas others have claimed that insulin can stimulate this process [18, 19] . It is important to reconcile these discrepancies, since this is vital in understanding fully the hormonal control of VLDL secretion. Glucagon, via cyclic AMP [20, 21] , and adrenaline, via a-adrenoreceptors [22] , decrease VLDL secretion from cultured hepatocytes. Hormones also modulate the secretion of components associated with HDL. Insulin and dexamethasone increase the secretion of apo A, by cultured rat hepatocytes [23, 24] . By contrast, glucagon decreases apo A, appearance in the medium [23] .
There is accumulating evidence that the mechanisms for the secretion for VLDL and HDL by the liver are different. For example, orotic acid inhibits the secretion of VLDL, but not of HDL [25] . Also, the secretion of both lipid and apolipoprotein components of VLDL, but not of HDL, are dramatically decreased in choline-deficient, compared with cholinesupplemented, hepatocytes [26] . The present studies were therefore undertaken primarily to investigate the interaction of insulin and dexamethasone on the secretion of apolipoproteins in VLDL. We have confirmed that the secretion of triacylglycerol was stimulated by dexamethasone and that insulin antagonized this effect [6] . The secretion of apo BH, apo BL and apo E in VLDL was then determined by measuring the incorporation of [3H]leucine and by immunotitration. Since apo E was also secreted in HDL and in the fraction of density > 1.18 g/ml, information is also provided about apolipoprotein secretion in these fractions. This provides a more complete picture of the factors controlling apo E secretion and the relation between VLDL and HDL production. The work was performed with primary monolayer cultures of rat hepatocytes, since this system has been well characterized in terms of the metabolic viability of the cells and their hormonal responsiveness in terms of lipid and lipoprotein metabolism [6, [27] [28] [29] [30] . The omission of insulin and glucocorticoid from the incubations does not decrease viability, as indicated by the retention of protein and lactate dehydrogenase activity. The cells Vol. 271 Abbreviations used: apo, apolipoprotein; BH, BL cultured in the absence of hormones also remain metabolically responsive and competent [6, [27] [28] [29] [30] . EXPERIMENTAL 
Materials
The sources of most of the materials have been described previously [6, [27] [28] [29] [30] . Acrylamide, NN'-methylenebisacrylamide, goat anti-(rabbit IgG)-alkaline phosphatase conjugate, goat anti-(mouse IgG)-alkaline phosphatase conjugate and Bio-Gel A-150 M (100-200 mesh) were purchased from Bio-Rad. L- [4,5-3H ]-Leucine (46-69 Ci/mmol) and [9,10( Dexamethasone and insulin were added at the concentrations indicated, and the cells were incubated for 14 h. In order to measure protein synthesis, the medium was replaced by an identical medium except that the leucine was decreased from 950 to 50/tM. The latter concentration supported almost maximum rates of protein synthesis. After a further incubation for 1 h, the medium was replaced with 2 ml of the equivalent leucine-depleted medium/dish containing about 43 ,uCi of [3H]leucine/ml and I mM-oleate, and the cells were incubated for 8 h. This time was chosen because the rates of secretion for triacylglycerol [6] and for apolipoproteins [32] are constant during this period. The medium from 7 or 8 dishes was collected and centrifuged at 10000 g for 10 min to remove cell debris. The hepatocytes were washed twice with ice-cold 0.16 M-NaCl and scraped from the plates in 1 ml of 0.25 M-sucrose containing 0.5 mM-dithiothreitol and 10 mM-Hepes adjusted to pH 7.4 with KOH.
Lipid secretion from the hepatocytes was measured in cells treated as described above but with normal, rather than leucinedepleted, Leibovitz L-15 medium, and the final incubation contained 1 The combined medium from 7 or 8 dishes was fractionated by a single-step ultracentrifugation procedure [32] . Lipoproteins in VLDL (d < 1.02 g/ml), LDL (1.02 < d < 1.06 g/ml), HDL (1.06 < d < 1.18 g/ml) and the bottom fraction (d > 1.18 g/ml) were concentrated by absorption on to fumed silica (Cab-O-Sil).
Apolipoproteins were solubilized from the Cab-O-Sil with 0.5 ml of 2 % SDS containing 6 M-urea for the VLDL and LDL fractions, and with 2.5 ml of reagent for the HDL and bottom fractions [32] . Samples (200 ul for VLDL and LDL, and 100 ,ul for HDL and the bottom fraction) were separated on SDS/PAGE by using 3-15 % gradient gels for VLDL and LDL and 12 % gels for HDL and the bottom fraction. The positions of the apolipoproteins on the gels were confirmed by using standards of VLDL and HDL prepared from rat serum [33] obtained with five concentrations of secreted VLDL, compared with those for standard VLDL (Fig. 1) .
Measurement of the relative size of the VLDL particles Hepatocytes were incubated in the absence or presence of insulin and dexamethasone as described above and for the last 8 h with 1 mM-[3H]oleate (16.6 Ci/mol). The combined medium (5 ml) was concentrated by about 5-fold in a dialysis bag by exposure to dry Sephadex G-100. Samples (0.5 ml) were then applied to a column (1.6 cm x 32 cm) of Bio-Gel A-1 50M agarose and eluted in 1 ml fractions by using f.p.l.c. at 0.16 ml/min with 0.16 mM-NaCl containing 0.01 % NaN3 and 0.1 % Na+ EDTA, pH 7.4. Lipids were extracted [34] , but without adding H3PO4 and KC1 and by using olive oil as a carrier [35] . Samples of the bottom phase of these extractions were diluted with 2 ml of chloroform, and then shaken with 1 g of basic alumina to remove residual oleate [28] . Portions (2 ml) of the chloroform extract were dried and 3H was determined by scintillation counting.
Determination of protein concentration and lactate dehydrogenase activity These were measured as described previously [6] . Expression of results and calculation of statistical significance
All results have been calculated relative to the units of lactate dehydrogenase present in the hepatocytes. This compensates for small variations among dishes of cells better than does the determination of protein or DNA [27, 28] , since some non-viable cells may remain attached to the plate and contribute to the last two values. Loss of viability is accompanied by leakage of lactate dehydrogenase into the incubation medium. The content of lactate dehydrogenase per dish of cells was 1.0 + 0.1 (n = 9) ,tmol of lactate oxidized/min, equivalent to 1 unit of activity at 22 'C. One dish of cells contains about 1 mg of protein, so that results can be readily expressed relative to protein if this is required for comparison with other work. The present incubations also contained about 13 mg of BSA/ml, and therefore the measurement of the relatively small concentration of hepatocyte protein might have been inaccurate for the routine determination of cell number. All results throughout the paper are given as means + S.E.M. for the numbers of independent experiments with hepatocytes from different rats that are shown in parentheses. P values were calculated by using a paired t test. In some instances the error bars in the Figures were too small to be indicated.
[Insulin] (nM) Fig. 2 (Fig. 2) . This apparent discrepancy probably reflects the preferential secretion of newly formed versus existing triacylglycerol, as observed previously [38] . Insulin at 10 nm and 50 nm decreased (P < 0.025) the [3H]triacylglycerol secretion by 35 % in each case, and decreased the mass of triacylglycerol in the medium by 38 and 600% respectively. Insulin (2-50 nM) also reversed (P < 0.01) the stimulating effects ofdexamethasone (Fig.  2) . These results are similar to those reported previously [6, 7] .
Effects of insulin and dexamethasone on protein synthesis and albumin secretion Dexamethasone decreased (P < 0.005) the incorporation of [3H]leucine into the proteins of the hepatocytes by about 24 % (Fig. 3a) . By contrast, insulin (2 nM) increased (P < 0.025) this incorporation by 40-70 %, and this increase was maintained (P < 0.05) in the presence of 100 nM-dexamethasone with 10 nm-and 50 nM-insulin (Fig. 3a) . The appearance of[3H]albumin in the bottom fraction obtained by ultracentrifugation of the incubation medium was not significantly affected by dexamethasone or insulin alone, but was increased by 2.1-2.6-fold when insulin was present with dexamethasone ( Fig. 3b) The interaction of insulin with dexamethasone depended on the concentration of insulin that was used. At 2 nM-insulin there was a further stimulation of apo B secretion above that obtained with dexamethasone alone (Figs. 4a-4b ). The increases in the presence of the two hormones were 4.4-fold (P < 0.05) and 7.2-fold (P < 0.005) for apo BH and apo BL respectively (Figs. 4a-4b ). However, there was no synergistic effect ofinsulin for the secretion of apo E. With 10 nm-and 50 nM-insulin these synergistic effects for apo BL and apo B H were lost, and the stimulations were not significantly different from those obtained with dexamethasone alone, probably because of the relatively large S.E.M. for the incorporations with dexamethasone alone. This degree of variation is to be expected when hepatocytes prepared from different animals are being used. However, the inhibitory effects of the higher insulin concentrations can be seen when the results with 2 nM-insulin are compared with those with 50 nM-insulin, both in the presence of dexamethasone. In the latter instance, the secretions of apo E, apo BH and apo BL were decreased significantly (P < 0.025, P < 0.05 and P < 0.05 respectively).
The masses of apo E and apo BH+L were determined by immunoassay. The results are essentially compatible with the effects observed with [3H]leucine incorporation. Insulin alone decreased (P < 0.05) the secretion of apo E (Fig. 4d) , whereas dexamethasone showed a striking increase (P < 0.025). dexamethasone. There were 3-7 independent experiments for each condition. The absolute incorporations of [3HJleucine into these apolipoproteins in the absence of hormones were 13.7 + 2.0 (n = 7), 15.8 + 3.6 (n = 6), 24 .3 + 5.2 (n = 7) and 44.5 + 10.5 (n = 7) pmol/unit of lactate dehydrogenase respectively in 8 h.
appearance of 3H-labelled apo BH, apo BL and apo E in LDL in the presence of 100 nM-dexamethasone were 1.5-, 1.6-and 1.9-fold, compared with 3.6-, 2.4-and 7.1-fold respectively in VLDL. There was no evidence for the hormones causing a significant shift of the particles between the VLDL and LDL density ranges.
Effects of insulin and dexamethasone on the sizes of VLDL particles The results in Figs. 2 and 4 show that the ratio of triacylglycerol to apo BH+L secreted in VLDL was changed by treatment of the hepatocytes with insulin and dexamethasone, which suggested that there were changes in the sizes of the VLDL particles in response to hormones. This was therefore investigated by labelling the triacylglycerol in the VLDL with [3H]oleate. Preincubation with dexamethasone, in the absence or presence of insulin, caused an increased secretion of both large and small particles (Fig. 5 ). An impression of the size of the secreted lipoproteins is obtained by reference to Mengo virus, which has a diameter of 30 nm and an apparent Mr = 8.4 x 106 [40] . This was eluted with a peak in fraction 33.
Effects of insulin and dexamethasone on the secretion of apolipoproteins in HDL and in the fraction of density > 1.18 g/ml There was no significant change in the secretion of the various apolipoproteins associated with HDL when the hepatocytes were incubated with insulin alone (Fig. 6 ). Dexamethasone alone also had little significant effect, although there was a significant 37 % increase (P < 0.05) in the secretion of [3H]apo AIV. However, with dexamethasone plus 2 nM-insulin there were larger increases of 77 %, 55 %, 74 % and 104 % for the fractions containing apo AI, apo AII plus apo C, apo AIV and apo E (P < 0.01, P < 0.05, P < 0.005 and P < 0.025 respectively). Similarly, significant increases were seen when 10 nm-or 50 nM-insulin was added with dexamethasone ( Fig. 6) .
The amount of apo E in the bottom fraction was even higher than that in the HDL fraction. For example, in the incubations that did not contain insulin or dexamethasone an average of 69 % of the total [3H]apo E was in the bottom fraction, compared with about 29 % in the HDL fraction ( Table 1 ). The addition of insulin and dexamethasone separately did not significantly alter the total secretion of apo E. However, when added together these hormones stimulated (P < 0.05) total apo E secretion to a similar extent (results not shown) to that in Fig. 6 for the HDL fraction.
DISCUSSION

Effects of hormones on VLDL secretion
The most striking novel findings from this work are the relatively large increases of 7.1-, 4.0-and 3.6-fold in the secretions in VLDL of apo E, apo BL and apo BH respectively when the hepatocytes were exposed to 100 nM-dexamethasone (Fig. 4) . The secretions of apo BH' and particularly apo BL, were further enhanced by the presence of 2 nM-insulin in the incubations. However, insulin alone inhibited the secretion of the three apolipoproteins in VLDL, and at 50 nm partly reversed the stimulatory effects ofdexamethasone. These results were obtained by labelling of apolipoproteins with [3H]leucine. Similarly, the results from the measurements of the masses of apo BH+L and apo E were compatible with the effects demonstrated by the leucine incorporations. Insulin and dexamethasone, either together or alone, have little significant effect on the synthesis of triacylglycerols in the hepatocyte system [6] , and therefore their effects appear relatively selective for the secretion process.
Changes in apolipoprotein secretion in VLDL were not simply non-specific effects on protein synthesis, because dexamethasone decreased the accumulation of total protein labelled with [3H]-leucine in the hepatocytes, and insulin had the opposite effect (Fig. 3) , as expected. Furthermore, the effects on the secretion of apolipoproteins in VLDL did not follow changes in overall protein secretion, since that of [3H]albumin was not significantly changed by incubating the hepatocytes separately with insulin or dexamethasone. However, incubation with both hormones in combination increased albumin secretion by 2.1-2.6-fold (Fig.  3 ). Higher concentrations of insulin did not reverse the effects of dexamethasone.
The inhibition of apo B secretion by insulin that we observed resembles that described by other investigators [11, 13, 15, 39] . However, Sparks et al. [15] failed to demonstrate a significant stimulation of apo B secretion when they incubated hepatocytes for [12] [13] [14] h with 100 nM-cortisol. This concentration of natural glucocorticoid is at the low end of the physiological range, since the basal concentration ofcorticosterone in unstressed rats varies between about 50 and 400 nm, depending upon the diurnal cycle [41] . The addition of 100 nM-corticosterone to rat hepatocytes fails to increase the activity of phosphatidate phosphohydrolase, but an increase can be readily seen with 1 UM-and 1O /CMcorticosterone [42] . It is probable that higher concentrations of corticosterone were required because hepatocytes degrade glucocorticoids. The present work employed a synthetic glucocorticoid, dexamethasone, which is relatively resistant to degradation. At the chosen concentration of 100 nm it stimulates the activities of tyrosine aminotransferase and phosphatidate phosphohydrolase [27, 28, 42] , increases triacylglycerol secretion [6] , and decreases the binding and degradation of LDL by hepatocytes [29, 30, 43] .
The mechanism by which dexamethasone stimulates apo B secretion (Fig. 4) Effects of insulin and dexamethasone on the secretion of HDL and albumin
The secretion of apolipoproteins in the HDL fraction showed a response to insulin and dexamethasone (Fig. 6 ) that differed from that for VLDL (Fig. 4) . These results demonstrate distinct mechanisms of hormonal control for these two lipoprotein classes. The secretion in HDL of apo AI, apo AIIplus apo C, apo AIV and apo E all responded in a similar way to the effects of dexamethasone and insulin. Individually these hormones had little effect on the secretion of the apolipoproteins in HDL. However, when added together the two hormones stimulated apolipoprotein secretion in HDL by 1.5-2-fold (Fig. 6 ). This pattern of response was similar to that for the secretion of albumin (Fig. 3b) . In other work with rat hepatocytes, insulin above 100 pM stimulated albumin secretion, and at concentrations above 10 nm inhibited apo Al secretion [23] . Part of the discrepancy between that and our work may have been caused by the preincubation of all hepatocytes with 1 uM-dexamethasone when they were plated by Masumoto et al. [23] . It [23] . It should also be noted that Crane & Miller [44] observed a stimulation of albumin secretion when insulin was added alone to cultures of rat hepatocytes. We therefore cannot fully explain the differences between our work and that of others on the effects of insulin on the secretion of albumin and apo A, except to say that the experimental conditions, including the presence of oleate in our culture media, were different from the work of others [23] .
The effects of dexamethasone in Fig. 3 are compatible with those found by Crane & Miller [44] , who reported no change in albumin secretion when hepatocytes were incubated with 78 /tMcortisol. Similarly, Masumoto et al. [23] showed no significant effect on the secretion of albumin and apo A, at 100 nMdexamethasone. However, apo Al secretion was increased when the concentration of dexamethasone was above 1 ,mM.
Lin [24] showed that incubating hepatocytes with either 1 ,UMinsulin or 1 ,uM-dexamethasone separately for 20 h had little effect on the secretion of apo A,. Insulin alone had little effect on apo E secretion, and dexamethasone alone decreased this process. However, when the hormones were added together there was a synergistic stimulation of the secretion of apo E and apo A,. Our results obtained from a 16 h preincubation with hormones resembled those of Lin [24] , except that we did not see inhibition of apo E secretion with dexamethasone. Lin [24] also extended the incubation period with hormones to 44 h. Insulin and dexamethasone each separately stimulated the secretion of apo A, and apo E. Synergism between the hormones was seen in the secretion of apo AI and apo E, but the effect on apo AIV secretion was only marginal. Those discrepancies that do exist between our Vol. 271 work and that of Lin [24] probably relate to the period of exposure to hormones and the fact that Lin [24] used concentrations of dexamethasone and insulin that were, respectively, 10-and 20-500-fold higher.
The mechanism by which insulin and glucocorticoids control the secretion of apolipoproteins associated with HDL is incompletely understood. However, it has been shown that insulin and dexamethasone, either separately or together, can increase the concentration of the mRNA for apo A, and apo AIV, but not that of apoE [45] . Mangeney et al. [46] concluded that the expression of the apo E gene is controlled by the glucagon/insulin ratio.
Control of apo E secretion
The majority of apoE secreted from the hepatocytes was probably not associated with lipoproteins, as has been shown from previous work [47, 48] . In our studies ( Fasting [49, 50] and refeeding [50] rats with carbohydrate (which may involve hormonal regulation) increases the production of apoE by the liver [43] . The increased production of apo E after fasting [49] , or sucrose feeding [50] , was accompanied by increases in apo E mRNA. However, addition of insulin and dexamethasone, separately or together, to hepatocyte cultures had no significant effects on the concentration of apo E mRNA [50] . Our own work shows no significant effects of these hormones when added separately on the total secretion of apo E, but increases (P < 0.05) of about 2-fold were obtained where these hormones were added together. The larger increases in apo E secretion in VLDL were probably a consequence of the increased secretion of VLDL particles and a corresponding increase in the association of apoE with these particles.
General effects of insulin and glucocorticoids on lipoprotein metabolism
The results in Figs. 2 and 4 confirm previous results [1] [2] [3] [4] [5] [6] [7] [8] showing that glucocorticoids stimulate the secretion of VLDL. However, the major contribution of the present work is that the secretion of apolipoproteins in VLDL (Fig. 4) was increased by dexamethasone to an even greater extent than that of the triacylglycerol (Fig. 2) . Furthermore, although dexamethasone stimulated the secretion of both large and small VLDL particles (Fig. 5) , a low concentration of insulin (2 nM) further enhanced the secretion of apo BL (Fig. 3b) . Synergistic stimulations between insulin and glucocorticoids also occur for the synthesis of glycogen [51] and fatty acids [52] [53] [54] [55] [56] and the activity of lipoprotein lipase in adipose tissue [57] . These reactions are all involved in energy storage, and the combined increase in both insulin and glucocorticoids which occurs in the circulation after meals [58] [59] [60] probably provides a signal for energy deposition [56, 61] . This same signal could be used for stimulating VLDL secretion, except that we observed a statistically significant synergism (in the sense of a mutually co-operative effect) only with respect to the secretion of apo BH, and particularly of apo BL (Fig. 3b) , but not for apo E (Figs. 4c and 4d) and triacylglycerols (Fig. 2) . However, we do not know the mechanism by which 2 nM-insulin was apparently increasing the effectiveness of the dexamethasone in terms of apo BL secretion, and further work on the interactions of glucocorticoids and insulin on VLDL secretion is warranted.
The results in Fig. 4 [68] [69] [70] . However, an alternative explanation is that the hypertriglyceridaemia is caused by a lack of insulin action on the liver as a result of insulinresistance and an enhanced glucocorticoid action [42, 45] . The present study emphasizes that glucocorticoids stimulate the secretion of VLDL particles. Insulin can suppress this process, but at low concentrations may act synergistically, as seen with apo BH and apo BL (Figs. 4a and 4b) .
The observed glucocorticoid-induced increase in the secretion of apo B in VLDL would be expected to result in an increased number of VLDL particles secreted, since there is assumed to be 1 molecule of apo B per VLDL particle [71] . Consequently, efficient insulin control in the liver could decrease the availability of VLDL particles in the circulation that ultimately will be converted to intermediate-density lipoprotein and LDL. Glucocorticoids would produce the opposite effect by increasing LDL production. The accumulation of LDL particles would also be increased by these latter hormones, since they decrease the availability of LDL receptors at the hepatocyte surface and the subsequent uptake of LDL [29, 30, 42] . In addition, glucocorticoids suppress the stimulatory action of insulin in this respect [29, 30, 42] . The combined results further strengthen the hypothesis that an increased control of metabolism by glucocorticoids can predispose humans to premature atherosclerosis [61] . However, the situation may be further complicated by the possible synergism between insulin and glucocorticoids in stimulating both apo B secretion, which is potentially atherogenic,
and HDL secretion, which should be protective. 
